glp-1 and mcas GLP-1s in with Dr. Tania Dempsey - Mast Cell Matters: Deep dives on MCAS with Tania Dempsey, MD - Presented by The POTScast Comprehensive mechanistic diagram showing GLP-1
Description
Both the stalk and ECL1 transform to a short -helix and form extensive interactions with the peptide, as shown in the previously reported peptide-bound active GCGR structure 9
A., Coulon, D
The pharmacological design of semaglutide includes three key structural alterations
Biochemical analysis showed that liraglutide normalized corticosterone levels and reduced activation of the hypothalamicpituitaryadrenal (HPA) axis, providing a neuroendocrine correlate for its anxiolytic-like effects
